sessions. As a rule it stops spontaneously without therapeutic intervention 2-3 h after the dialysis Atrial fibrillation is regarded as the most frequent session [2] . supraventricular cardiac arrhythmia. Its incidence in the adult population is 0.5%. The probability of developing atrial fibrillation rises with increasing age. The
Framingham study reports an incidence of 0.4% for Clinical features persons under 30 years, whereas atrial fibrillation is observed in 2-4% of persons aged over 60 years.
The clinical presentation of atrial fibrillation depends Secondary forms resulting from cardiac and extra-mainly on the rate of ventricular contraction. Whereas cardiac diseases must be distinguished from the rarer atrial fibrillation of normal frequency is mostly asympprimary (idiopathic) forms of atrial fibrillation without tomatic, 'palpitations' are typically reported at a high concomitant cardiac disease ( lone atrial fibrillation) ventricular contraction rate. Apart from the high vent- [1] . ricular contraction rate, the underlying cardiac condiWithout consideration of the aetiology and for tion is crucial for clinical presentation, i.e. angina reasons of practicability, atrial fibrillation is subdivided pectoris, dyspnoea, pulmonary oedema. Vertigo or clinically into: orthostatic dysregulation are frequent, and even syncope may occur. (i) Paroxysmal atrial fibrillation, which occurs episodically and converts spontaneously into sinus rhythm within 48 h at the most.
(ii) Persistent atrial fibrillation, which is sustained for Haemodynamics longer than 48 h, but which continues to be convertible into sinus rhythm. Not only the atrial primer pump function (atrial 'kick'), (iii) Permanent atrial fibrillation, which can no longer but also the powerful synchronous atrial contraction be converted into sinus rhythm with conventional is lost when atrial fibrillation occurs. Consequently, treatment measures. development of atrial fibrillation causes relevant clinThe classification is clinically relevant since parox-ical and haemodynamic deterioration, especially in ysmal atrial fibrillation can be converted by medication elderly people [4] . or by electrical means without prior anticoagulation, At present a major increase in volume of the right whereas an attempt at conservative treatment is no and left auricles is viewed by some authors [5] as a longer appropriate in patients with permanent atrial further potential factor predisposing to atrial fibrillafibrillation. If clinical symptoms are present, invasive tion. This is particularly relevant for patients undertreatment should be considered. In persistent atrial going dialysis. fibrillation, effective anticoagulant treatment for at Haemodynamic impairment is in part explained by least 3 weeks is indicated before attempting conversion, shortening of the diastole and impaired left ventricular in order to avoid thromboembolic complications.
filling. In part, however, it is also due to altered systolic Since atrial fibrillation tends to occur in cases with contractility. The staircase phenomenon (Bowditch's cardiac pathology, it is not surprising that intermittent treppe) implies that cardiac contractility increases as atrial fibrillation occurs in dialysis patients (16%) heart rate goes up until a maximum is reached. This significantly more often than in the general popula-maximum differs from individual to individual, tion [2] .
depending on the state of training and underlying In the Canadian Multicenter Study, pathological cardiac disease. In patients with a high ventricular echocardiographical findings were seen in 75% of contraction rate the peak of Bowditch's is reached at patients admitted for renal replacement therapy [3] . heart rates of no more than 80-90/min, so that any further increase of heart rate leads to a progressive decrease of cardiac contractility ('tachycardia treatment in most patients, especially those with paroxElectrophysiology ysmal atrial fibrillation. The electrophysiology of atrial fibrillation is characterized by the presence of multiple small wavefronts and (ii) Pharmacotherapy a very short excitable gap. During atrial fibrillation, It is beyond the scope of this editorial to discuss all the electrophysiological properties of the auricular antiarrhythmic agents in depth. We restrict the discusmyocardium change further: the atrial refractory phase sion to those agents that are likely to be used by the shortens so that atrial fibrillation is perpetuated. clinical nephrologist. Depending on the duration of pre-existing atrial fibrillation, this 'electrophysiological remodelling' can persist even after successful conversion into sinus rhythm. Antiarrhythmic class 1A and class 1C agents
It is therefore ever more improbable that sustained conversion can be achieved, the longer atrial fibrillation
On the basis of electrophysiological and clinical studies, had been present [6 ] .
class 1A and 1C drugs are recommended for rapid conversion of atrial fibrillation into sinus rhythm.
Prognosis
Class 1A According to the results of many studies, it is question-Quinidine able whether atrial fibrillation per se is associated with Quinidine is still given as the first-line medication for higher mortality. This is true even for patients who conversion of atrial fibrillation into sinus rhythm by have suffered acute myocardial infarction with congest-60-80% of doctors in the United States [9] . Quinidine ive heart failure or stroke. Nevertheless an in-hospital is eliminated to some extent by renal excretion mortality from atrial fibrillation of about 8% has been (15-40%) but mainly by the liver (60-85%). Therefore, reported [7] .
in principle its use in dialysis patients is possible. It Atrial fibrillation is of particular clinical importance should be borne in mind, however, that the half-life of mainly because of the increased rate of stroke: atrial quinidine which is 9-19 h in normals [10,11] is substanfibrillation is an independent risk factor for stroke, tially prolonged. It is not only this pharmacokinetic increasing the risk by a factor of 3-5. At present it property that makes the administration of quinidine cannot be stated with certainty whether modern treat-risky in dialysis patients, but also its substantial proment of atrial fibrillation, including anticoagulation arrhythmic effect. The latter is of considerable imporand normalization of the ventricular contraction fre-tance in patients with underlying cardiac disease or in quency, alters the prognosis of atrial fibrillation. patients with electrolyte disorders or in patients underNevertheless, the data of the Framingham study [8] going electrolyte shifts. The dreaded 'torsade de indicate that whenever possible atrial fibrillation should pointes' occurs with a frequency of 8% per patient be treated at an early stage to prevent development of year, a figure that is presumably even an underestipermanent atrial fibrillation.
mate [12, 13] . Conversion of atrial fibrillation into sinus rhythm Quinidine prophylaxis against paroxysmal atrial fibas quickly as possible (or at least normalization of the rillation may be harmful, since the mortality under ventricular contraction rate) is therefore the first goal quinidine therapy was reported to be 2.9%, significantly of treatment, especially in patients with cardiac disease. higher than in the control group (0.8%, P<0.05) [14] .
Theoretically the combination of quinidine and verapamil is rational. On the one hand the combination
Criteria for therapy
was shown to be effective in studies both on conversion of atrial fibrillation and on prophylaxis to prevent Treatment of atrial fibrillation aims at controlling the recurrence [15, 16 ] . On the other hand, proarrhythmic ventricular contraction rate and improving comprom-effects could still be observed with combination treatised haemodynamics. Whenever possible, however, ment [17] . The SOPA study, currently in progress, is cardioversion should be tried in order to restore sinus designed to test the effectiveness and safety of this rhythm.
combination in the treatment of paroxysmal atrial fibrillation [17] .
(i) Non-drug treatment Disopyramide
Disopyramide is effective to treat acute atrial fibrillaIn severely compromised patients with impaired consciousness, pharmacotherapy should not be tried. tion and to prevent recurrences. Unfortunately, it has a strong negative inotropic effect and increases periTransthoracic electroshock is the treatment of choice in such patients. A high-energy dose (400 J ) should be pheral vascular resistance. Its administration is no longer appropriate in patients with pre-existing cardiac applied immediately in synchronous discharge mode.
Such a dramatic situation is rare in cases of atrial damage. Moreover, clinically relevant stimulation of insulin secretion with subsequent hypoglycaemic shock fibrillation. Pharmacotherapy is the primary form of was observed in dialysis patients when disopyramide improvement of haemodynamics. Moreover, a decrease in blood pressure was only rarely observed, and if was administered [18] . present it was of short duration. The baseline blood pressure was restored within 4-10 min after adminisClass 1C tration [21, 22] .
Propafenone
Esmolol is metabolized by erythrocyte esterase, so In recent years it has been pointed out repeatedly that that there are no pharmacokinetic restrictions to propafenone can be used successfully not only in acute administer a single dose of this compound in patients atrial fibrillation, but also as a prophylactic agent to with end-stage renal failure [8] . Nevertheless, its metaprevent recurrences. Since propafenone is almost bolites accumulate, and esmolol should not be adminisexclusively (99%) metabolized and excreted via the tered more than once in a 4 h interval. Adaptation of liver, its use in dialysis patients is not contraindicated the dose is not necessary [22] . in principle. Nevertheless, a disadvantage is the relaIf sinus rhythm is not restored, because of the short tively long half-life: 12 h in patients with rapid metabol-half-life of esmolol, it is possible to switch to other ism and up to 32 h in patients with slow metabolism agents without delay. Overlapping administration of [19] . Such uncertainty with respect to the half-life is other beta blockers (e.g. metoprolol ) has been shown problematic, especially in dialysis patients.
to cause no problems.
Other class 1C drugs
Class III The CAST (Cardiac Arrhythmia Suppression Trial ) studies I and II investigated the antiarrhythmic activity Sotalol of other class 1C drugs (flecainide, encainide, and In patients without renal disease, sotalol is used sucmoricizine). The results caused considerable concern cessfully both for treating acute atrial fibrillation and since the number of sudden deaths in the study group for preventing its recurrence. Since sotalol is mainly tended to be higher compared to a control group excreted via the kidneys, its use in dialysis patients treated with placebo (although the difference was not cannot be recommended, especially in view of its always significant). Today these drugs should be clinically relevant proarrhythmic effect, particularly the administered very cautiously, if at all, and this is risk of torsade de pointes even at normal plasma levels. particularly true for patients with myocardial disease Torsade de pointes is a form of polymorphic ventri- [20] . cular arrhythmia. It is characterized by the fact that the electrical axis rotates around the isoelectric line.
Class II
The heart rate is in the range of 150-300/min with varying RR intervals. Torsade de pointes occurs on a Besides the classical antiarrhythmic agents, beta background of a prolonged QT interval, reflecting blockers have now regained a position of prominence prolonged cardiac repolarization [23] . Therefore drugs in the treatment of tachycardiac arrhythmias, especially that prolong the duration of the action potential in view of the CAST studies. Nevertheless, when using predispose to this life-threatening arrhythmia. Extreme beta blockers one should be aware of the appreciable caution in the indication and use of sotalol in dialysis differences in the pharmacodynamic profile, and especi-patients is warranted, especially in women who are ally the major substance-specific differences with regard more prone to torsade de pointes than men. Because to plasma half-lives. We would like to point out, it occurs most frequently during the first days of however, that half-lives do not correspond to the therapy, a daily dose of 40 mg should not be exceeded duration of action at the receptor level.
during the titration phase. The QT interval has to be monitored by daily ECG controls. The medicaPropranolol and metaprolol tion should be stopped immediately if excessive QT At present, more than 50 different beta blockers are prolongation occurs [24] . on the market in the Federal Republic of Germany. Apart from propranolol, metoprolol is particularly suitable for use in dialysis patients. It is lipophilic and Amiodarone b1-selective, and of proven efficacy.
In patients with frequent paroxysmal atrial fibrillation, low doses of amiodarone can be recommended as Esmolol prophylaxis against recurrence. However, the drug is Esmolol is a highly cardioselective beta blocker that associated with a high rate of side-effects (hypothyroidcan be injected intravenously. It differs from all other ism, hyperthyroidism, photosensitization of the skin, beta blockers by its very short half-life of only 10 min. lens opacity) [25, 26 ] . Esmolol proved to be very effective in treating atrial fibrillation with tachyarrhythmia. In a comparison Class IV drugs with verapamil, the rate of conversion after administration of an esmolol bolus of 10 or 20 mg was signific-Verapamil For many physicians, verapamil is still the standard antly greater (four times greater) than after 5 or 10 mg verapamil i.v. In every case, the heart rate could be first-line treatment for absolute tachyarrhythmia, especially because of the rapid onset of the bradycardic effectively reduced, giving rise to a corresponding 10. Benet LZ, Oie S, Schwartz JB. Design and optimization of effect [27] . Verapamil treatment occasionally causes dosage regimens; pharmacokinetic data. In: Hardmann JG, severe hypotension and excessive bradycardia, and this Gilmann AG, Limbird LE, eds, Goodmann A Gilman's The may occur up to 4-6 h after a single i.v. bolus [28] . 
